Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KDNY | CHINOOK THERAPEUTICS, INC. | Chief Commercial Officer | $932K | Aug 11, 2023 | ||
KLRS | Kalaris Therapeutics, Inc. | President and Chief Executive Officer, Director | Apr 10, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|